Embarking on the global biotech stage, the allure of the Chinese market beckons with undeniable potential. Yet, the path to licensing biotech products in China has its own set of challenges. The intersection of innovation, regulation, culture, and market dynamics creates a complex tapestry that demands careful navigation. Click here to download the document.

About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *